Pancreatic Cancer News & Features
A particular microRNA could prove to be a potent therapeutic agent against pancreatic cancer, according to new research.
A protein encoded by the gene glypican-1 present on cancer exosomes may be used as part of a potential non-invasive screening tool to detect early pancreatic cancer.
People with pancreatic cancer or ampullary cancer reported very high levels of needs.
A protein encoded in the glypican-1 (GPC1) gene may allow for a non-invasive screening tool to detect early pancreatic cancer.
A common antibiotic, when combined with an experimental drug, may have a role in pancreatic cancer treatment.
- Multiple myeloma uses "wolf in sheep's clothing" tactic to avoid immune response in bone
- Comparison of zoledronic acid dosing schedules finds less frequent schedule noninferior
- HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence
- Delayed referrals, diagnoses undermine cancer patients' faith in health care system
- Alcohol Consumption Linked with Less Disability in Chronic Pain
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|